← FDA Drug Approvals (Drugs@FDA)

NORFLEX

NDA · New Drug Application · Sponsor: BAUSCH · Approved 1959-11-04

Drug application

FDA Application #

NDA012157

Application type

New Drug Application

Brand name

NORFLEX

Generic name

Orphenadrine Citrate

Active ingredients

ORPHENADRINE CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

BAUSCH

First approval

1959-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown